TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Heat detection threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heat-pain threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Waist to hip ratio (WHR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall preference of chocolate chip cookies
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Joint pain (10-cm visual analog scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Childhood Health Assessment Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 3-year local control rate
Endpoint domain: Mortality/survival
Primary endpoint: 3-year locoregional control rate
Endpoint domain: Mortality/survival
Primary endpoint: Number of nevi
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: overall wound/infectious morbidity
Endpoint domain: Adverse events/effects
Primary endpoint: False-positive diagnoses prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: FN diagnosis prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Diagnostic accuracy of CTA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: myocardial infarction
Endpoint domain: Adverse events/effects
Primary endpoint: sternal wound reoperation
Endpoint domain: Adverse events/effects
Primary endpoint: Number of bleeding events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: level of menstrual distress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Go test scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: regional cerebral glucose metabolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Gestational diabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: restful sleep at home
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: decrease in PtcCO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: MMP-8 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Levels of IgG4 to grass mix allergen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Immediate and delayed cutaneous responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: antibiotic prescription rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-Traumatic Stress Symptoms (PTSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1-year ITSQ total score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Volume of intraoperative blood loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Therapeutic effect evaluated by Nakai standard
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Emergence of N348I mutation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Virologic failure of first-line ART
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduced susceptibility to NVP, EFV, ETV, and AZT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete/near-complete resolution of distant untreated warts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Deaths from any cause at 1 year
Endpoint domain: Mortality/survival
Primary endpoint: ICU adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: hip kinematics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ocular chlamydial infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: %EWL (Percentage of Excess Weight Loss)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for photocoagulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Total clearance of bambuterol and terbutaline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Mean terminal half-life of bambuterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bioavailability of terbutaline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: uptake of GDM screening
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Unprotected anal insertive sex
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative pain scores during coughing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual analogue scores for pain relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: symptom distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: continence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: obstructive urinary symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: FACT-HN total score change
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: three-point MACE events averted
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: costs avoided PMPY
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: costs avoided for heart failure
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Median decrease in drop seizures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Percentage of patients drop-seizure-free
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Global evaluation of improvement by parents and physicians
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: hematocrit increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive functions recovery
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Verbal memory and reading capacity deficits
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Response rate based on 50% decrease in MADRS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discontinuation rate due to lack of efficacy
Endpoint domain: Adverse events/effects
Primary endpoint: GLP-1 secretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: mortality at 28 days
Endpoint domain: Mortality/survival
Primary endpoint: days free of nonpulmonary organ failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MDS‐UPDRS‐3 score reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: onset time for block of the T7 dermatome to touch
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: preparation time for local anaesthetic mixture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: need for additional local anaesthetic or analgesic supplements
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical remission at week 54
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical response at week 54
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Global Impressions scales response rates
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Brief Social Phobia Scale scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Subjective Units of Distress Scale assessment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Objective cure of SUI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Compliance to MNP consumption
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Brachial artery FMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: significant blanching response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recurrent hernia >2 cm
Endpoint domain: Mortality/survival
Primary endpoint: quality of life (SF-36)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Preventive service delivery rates
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Peak attained oxygen uptake (VO2max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxygen uptake at ventilatory threshold (VeT VO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: extubation failure rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Overall IKDC score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective IKDC score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Arthritic progression
Endpoint domain: Adverse events/effects
Primary endpoint: Relative peak torque
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lean body mass (LBM) change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abduction ability improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Mean diffusion-weighted imaging (DWI) lesion growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of state-anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Observed anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Parental anxiety scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Compliance of the child
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of ischemic complications
Endpoint domain: Mortality/survival
Primary endpoint: Unplanned revascularization procedures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Aesthetic outcome of uvula reconstruction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of psychotropic medication
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Hemoglobin levels at the first and 24th hour of life
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: time spent on screen viewing
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: HCV-RNA negativity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum concentrations of serum amyloid A
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Serum concentrations of interleukin 6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Serum vitamin E levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Copper-induced in vitro peroxidizability of LDL and VLDL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of death, myocardial infarction, or stroke
Endpoint domain: Mortality/survival
Primary endpoint: Psychological General Well‐Being Schedule
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Nurses Observation Scale for Inpatient Evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MLHFQoL improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Decrease in ejection fraction > or = 15%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Development of clinical congestive heart failure
Endpoint domain: Adverse events/effects
Primary endpoint: Mortality from pneumonia or R equi infections
Endpoint domain: Mortality/survival
Primary endpoint: Positive predictive value for dementia patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity to identify hospitalized patients with dementia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: High-density lipoprotein cholesterol increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Primary patency at 5 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Efficacy rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Rate of psychiatric hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: Dose-Area Product (DAP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient Effective Dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: toe alignment in the sagittal plane
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: foot outcome scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: International Standards for Neurological Classification of Spinal Cord Injury total motor score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: 10-meter walk test speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: 6-minute walk test total distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cerebral performance categories score of one or two
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Preference for labor management
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Frequency of contractions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: duration of antibiotic treatments
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Reduction in headache-related disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Decrease in HDI scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median percentage reduction in AK number
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: AChR antibody titer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Transfusion requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in kinesiophobia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total tumor resection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cure of cerebrospinal fluid leak
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: capacity to recall emotion-related interpersonal information
Endpoint domain: Cognitive functioning
Primary endpoint: Improvement in SF-36 scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Reduction in Visual Analogue Scale for low back pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in Visual Analogue Scale for leg pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retinal attachment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retinal redetachment
Endpoint domain: Adverse events/effects
Primary endpoint: Iris neovascularization regression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total circulating neutrophil numbers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Infarct size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Severity and frequency of hallucinations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Negative symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: HbA(1c) lowering
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dextrorphan/dextromethorphan metabolic ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plasma perhexiline concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cis-OH-perhexiline/perhexiline ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: option regret
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Brehaut regret
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Antibiotic use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: gain of knowledge and skill
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total costs of therapies
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Postoperative pain values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve of CK-MB release
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: difficulties in sustained attention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: adipocyte size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: capillary density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum adiponectin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Satisfaction with content
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Satisfaction with presentation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Desire for additional information
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of tuberculin conversion as measured by the Heaf test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Visibility of BCG scar
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain and inflammatory response
Endpoint domain: Adverse events/effects
Primary endpoint: Mean change in Mg concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of patients with Mg within reference range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Clinical improvement of constipation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Constipation scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean percent change from baseline in AJC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: angiographic ISR rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: lumen area loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: operation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Potential candidates for statin therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean haemoglobin (Hb) loss during surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: blood loss during or after TURP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: urinary incontinence
Endpoint domain: Adverse events/effects
Primary endpoint: Polyp regression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ki‐67(s) labeling index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Apoptotic ratio (AI(s)/AI(ns))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: deep wound infection
Endpoint domain: Adverse events/effects
Primary endpoint: revision surgery rates
Endpoint domain: Adverse events/effects
Primary endpoint: Production of TNFalpha
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: UPDRS II score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: UPDRS III score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sleep scale score
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Clinical Cure Rate (CCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fetal heart rate response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fetal movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fetal startle response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean microgap at the implant-abutment interface
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recognition score in quiet conditions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes